|
|
|
Canada Business News and Press Releases
|
(EMAILWIRE.COM, October 21, 2009 ) Windsor, Ontario – Thepennystockpicks.com is an online financial publication, provides investors timely penny stock market alerts. If you are interested in penny stocks that are poised to breakout sign up for our free penny stock newsletter. Each day we send out alerts on different hot penny stocks. For more FREE ALERTS SIGN UP AT http://www.thepennystockpicks.com
Aethlon Medical, Inc. (AEMD) announced today that research studies have documented the Aethlon Hemopurifier® is effective in capturing the current pandemic strain of the H1N1 Swine Flu Virus. The Hemopurifier® Hemopurifier® is the first-in-class medical device able to selectively remove infectious viruses and immunosuppressive proteins from the bloodstream. During invitro studies, the Hemopurifier® removed 68% of H1N1 virus from blood plasma in 30 minutes, 80% of the virus in two hours, and a 96% reduction of H1N1 was observed at six hours. The studies were performed by third party researchers approved by the United States Department of Health and Human Services (HHS) to house and conduct research on the current pandemic strains of H1N1 virus.
"The confirmation of the same Hemopurifier® we are advancing in Hepatitis-C (HCV) care, having significant activity against H1N1 virus is quite timely when considering the evolving rate of the pandemic," stated Aethlon Chairman & CEO, Jim Joyce.
In the last trading session, the stock closed at $0.285. The company hit $0.49 on well above average trading volume.
Health Discovery Corporation (HDVY) is pleased to announce numerous additional issued patents and Notices of Allowance since its last press release describing its intellectual property portfolio. The Company now has a total of 37 issued patents, 4 Notices of Allowance and 30 pending patent applications.
The United States Patent and Trademark Office (USPTO) issued a patent to HDC that includes additional, broader claims to the Company’s exclusive Recursive Feature Elimination (RFE) using Support Vector Machines (“SVM”) or SVM-RFE method, the first patent for which issued in 2006. The SVM-RFE method has been used to successfully identify the most important pieces of information needed to solve complex pattern-recognition problems and has been shown in numerous peer-reviewed publications from some of the world’s top academic institutions to be a superior technology for the successful discovery of new molecular diagnostic/prognostic tests for personalized medicine. HDC has the only issued patents in the world for the SVM-RFE technology, which was discovered by members of the HDC science team. The SVM-RFE technology was the method used to discover the Company’s new tissue and urine based prostate cancer tests recently licensed to Quest Diagnostics (DGX), Abbott Laboratories (ABT) and Clarient Inc. (CLRT).
In the last trading session, the stock closed at $0.38. The company reached $0.43 on well above average trading.
About Thepennystockpicks.com
Thepennystockpicks.com alerts its members on any stocks from penny stocks to NYSE stocks. Our penny stock forum offers free penny stock trading videos, trading software and penny stock broker reviews to our members. Our investing forum has discussions on hot penny stocks to long term investments. All the penny stocks that we alert on have above average trading volume, strong news and penny stocks that are moving to the upside quickly. Our penny stock newsletter is great for investors who are starting in the stock market and want a place for information. If you are interest in seeing hot penny stocks and want free penny stock picks come visit http://www.thepennystockpicks.com for a free membership. We also track small cap companies and other stocks that may be positioned to break out. Free Hot Penny Stocks is not a registered investment advisor or broker-dealer. Please do your own Due Diligence before investing in any of the stocks mentioned above.
Please click here to read the full disclaimer at http://www.thepennystockpicks.com/disclaimer/
Resultz Media
Michael Ryan
877-301-9737
staff@thepennystockpicks.com 
|
|
|
|
